Search Results

There are 17289 results for: content related to: Bevacizumab nasal spray: Noninvasive treatment of epistaxis in patients with rendu-osler disease

  1. Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: A double-blind, randomized, placebo-controlled trial

    Head & Neck

    Volume 37, Issue 6, June 2015, Pages: 783–787, Dominik Riss, Martin Burian, Axel Wolf, Veronika Kranebitter, Alexandra Kaider and Christoph Arnoldner

    Version of Record online : 30 APR 2014, DOI: 10.1002/hed.23655

  2. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: Effectiveness of an injection protocol based on the vascular anatomy of the nose

    The Laryngoscope

    Volume 122, Issue 6, June 2012, Pages: 1210–1214, Sinan Dheyauldeen, Amy Østertun Geirdal, Terje Osnes, Liv Sofie Vartdal and Ralph Dollner

    Version of Record online : 7 MAY 2012, DOI: 10.1002/lary.23303

  3. You have free access to this content
    Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas

    Cancer

    Volume 116, Issue 17, 1 September 2010, Pages: 3988–3999, Marc C. Chamberlain

    Version of Record online : 19 AUG 2010, DOI: 10.1002/cncr.25256

  4. Angiogenesis inhibitors for the treatment of ovarian cancer

    Intervention Review

    The Cochrane Library

    Kezia Gaitskell, Igor Martinek, Andrew Bryant, Sean Kehoe, Shibani Nicum and Jo Morrison

    Published Online : 7 SEP 2011, DOI: 10.1002/14651858.CD007930.pub2

  5. Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases

    British Journal of Surgery

    Volume 98, Issue 3, March 2011, Pages: 399–407, D. A. Wicherts, R. J. de Haas, M. Sebagh, E. Saenz Corrales, D. L. Gorden, F. Lévi, B. Paule, D. Azoulay, D. Castaing and R. Adam

    Version of Record online : 15 DEC 2010, DOI: 10.1002/bjs.7368

  6. Retina, Vitreous

    Clinical & Experimental Ophthalmology

    Volume 36, Issue s1, June 2008, Pages: A459–A584,

    Version of Record online : 18 JUL 2008, DOI: 10.1111/j.1442-9071.2008.01760.x

  7. Efficacy of intranasal bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis

    The Laryngoscope

    Volume 121, Issue 3, March 2011, Pages: 636–638, Tom T. Karnezis and Terence M. Davidson

    Version of Record online : 16 DEC 2010, DOI: 10.1002/lary.21415

  8. Safety of intranasal Bevacizumab (avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis

    The Laryngoscope

    Volume 121, Issue 3, March 2011, Pages: 644–646, Sonia Chen IV, Tom Karnezis and Terence M. Davidson

    Version of Record online : 11 NOV 2010, DOI: 10.1002/lary.21345

  9. You have free access to this content
    Anti-vascular endothelial growth factor for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Sharon D Solomon, Kristina Lindsley, Satyanarayana S Vedula, Magdalena G Krzystolik and Barbara S Hawkins

    Published Online : 29 AUG 2014, DOI: 10.1002/14651858.CD005139.pub3

  10. The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia

    The Laryngoscope

    Volume 119, Issue 5, May 2009, Pages: 988–992, Jana Simonds, Frank Miller, Jess Mandel and Terence M. Davidson

    Version of Record online : 4 FEB 2009, DOI: 10.1002/lary.20159

  11. Hereditary hemorrhagic telangiectasia–related epistaxis: innovations in understanding and management

    International Forum of Allergy & Rhinology

    Volume 2, Issue 5, September/October 2012, Pages: 422–431, Nathan B. Sautter and Timothy L. Smith

    Version of Record online : 7 MAY 2012, DOI: 10.1002/alr.21046

  12. You have free access to this content
    Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Lorenzo Moja, Ersilia Lucenteforte, Koren H Kwag, Vittorio Bertele, Annalisa Campomori, Usha Chakravarthy, Roberto D'Amico, Kay Dickersin, Laurent Kodjikian, Kristina Lindsley, Yoon Loke, Maureen Maguire, Daniel F Martin, Alessandro Mugelli, Bernd Mühlbauer, Isabel Püntmann, Barnaby Reeves, Chris Rogers, Christine Schmucker, Manju L Subramanian and Gianni Virgili

    Published Online : 15 SEP 2014, DOI: 10.1002/14651858.CD011230.pub2

  13. Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer

    Intervention Review

    The Cochrane Library

    Anna Dorothea Wagner, Christoph Thomssen, Johannes Haerting and Susanne Unverzagt

    Published Online : 11 JUL 2012, DOI: 10.1002/14651858.CD008941.pub2

  14. Intravenous bevacizumab for complications of hereditary hemorrhagic telangiectasia: a review of the literature

    International Forum of Allergy & Rhinology

    Volume 5, Issue 11, November 2015, Pages: 1042–1047, Natalia P. Arizmendez, Luke Rudmik and David M. Poetker

    Version of Record online : 22 JUL 2015, DOI: 10.1002/alr.21587

  15. Cost-utility analysis of bevacizumab versus ranibizumab in neovascular age-related macular degeneration using a Markov model

    Journal of Evaluation in Clinical Practice

    Volume 18, Issue 2, April 2012, Pages: 247–255, Jignesh J. Patel, Margaret A.S. Mendes, Mark Bounthavong, Melissa L.D. Christopher, Daniel Boggie and Anthony P. Morreale

    Version of Record online : 16 SEP 2010, DOI: 10.1111/j.1365-2753.2010.01546.x

  16. You have free access to this content
    Early vitreoretinal surgery on vascularly active stage 4 retinopathy of prematurity through the preoperative intravitreal bevacizumab injection

    Acta Ophthalmologica

    Volume 91, Issue 4, June 2013, Pages: e304–e310, Yu Xu, Qi Zhang, Xiaoli Kang, Ying Zhu, Jiakai Li, Yiye Chen and Peiquan Zhao

    Version of Record online : 7 MAY 2013, DOI: 10.1111/aos.12055

  17. You have free access to this content
    Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery

    Acta Ophthalmologica

    Volume 93, Issue 7, November 2015, Pages: 667–678, Tine Van Bergen, Evelien Vandewalle, Lieve Moons and Ingeborg Stalmans

    Version of Record online : 18 MAY 2015, DOI: 10.1111/aos.12766

  18. You have free access to this content
    Bevacizumab-induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab

    Cancer

    Volume 121, Issue 9, May 1, 2015, Pages: 1456–1462, Jim Zhong, Arif N. Ali, Alfredo D. Voloschin, Yuan Liu, Walter J. Curran Jr, Ian R. Crocker and Hui-Kuo G. Shu

    Version of Record online : 29 DEC 2014, DOI: 10.1002/cncr.29234

  19. Anti-angiogenic therapies for metastatic colorectal cancer

    Intervention Review

    The Cochrane Library

    Anna Dorothea ADW Wagner, Dirk Arnold, Axel AG Grothey, Johannes Haerting and Susanne Unverzagt

    Published Online : 8 JUL 2009, DOI: 10.1002/14651858.CD005392.pub3

  20. You have free access to this content
    Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies

    Cancer

    Volume 121, Issue 7, April 1, 2015, Pages: 997–1007, Kathryn M. Field, Justin T. Jordan, Patrick Y. Wen, Mark A. Rosenthal and David A. Reardon

    Version of Record online : 26 SEP 2014, DOI: 10.1002/cncr.28935